COVID-19: Statement Regarding the Management of Minimal, Mild and Moderate Head Injury

SNC statement COVID-19

Due to the huge stress on the health care system under the current pandemic COVID-19, situations may occur where limited resources require triage and prioritizing of patient admissions in a manner normally not seen in the Nordic countries. This will also affect patients with acute traumatic brain injury (TBI). Given that COVID-19 infection in older patients and in those with comorbidities, have a potentially higher mortality rate than the TBI itself, and that the risk of infection in hospitals may be increased, the SNC suggests that during this limited period, the Scandinavian adult TBI guidelines should be weighed against the individual risk of a COVID-19 infection. In this situation we support that temporary deviance from the guidelines can be motivated and guided by risk-benefit as outlined in the statement above.

The Scandinavian head injury trial in pediatric patients

The Scandinavian head injury trial in pediatric patients i.e. “the SHIPP-study” is a pragmatic, prospective, multicentre study for the validation of the Scandinavian guidelines for minor and moderate head trauma in children. The study is actively looking for more hospitals in Sweden, Norway, Finland and Denmark that want to participate. Please send an e-mail to info@shipp.se and we will contact you with more information.

Andrew Maas updates the SNC on the CENTER-TBI study

Today, Andrew Maas, Professor and Chairman of the Department of Neurosurgery at the Antwerp University Hospital andUniversity of Antwerp, and project coordinator of the CENTER-TBIstudy gave an excellent presentation to the SNC members. He presented the current status of the CENTER-TBI study and announced an upcoming special issue of the Lancet Neurology, dedicated to traumatic brain injury.